m-Eslon SR Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

m-eslon sr

multichem nz limited - morphine sulfate pentahydrate 100mg;   - modified release capsule - 100 mg - active: morphine sulfate pentahydrate 100mg   excipient: dibutyl sebacate ethylcellulose gelatin   macrogol 4000 purified talc sugar spheres titanium dioxide - for the prolonged relief of chronic, moderate to severe pain in adults. use in non-malignant pain: the use of m-eslon sr tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: o all other conservative methods of analgesia have been tried and have failed; o the pain is having a significant impact on the patient's quality of life; o there is no psychological contraindication, drug seeking behaviour or history of drug misuse.

m-Eslon SR Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

m-eslon sr

multichem nz limited - morphine sulfate pentahydrate 10mg;   - modified release capsule - 10 mg - active: morphine sulfate pentahydrate 10mg   excipient: dibutyl sebacate ethylcellulose gelatin   macrogol 4000 purified talc quinoline yellow sugar spheres titanium dioxide - for the prolonged relief of chronic, moderate to severe pain in adults. use in non-malignant pain: the use of m-eslon sr tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: o all other conservative methods of analgesia have been tried and have failed; o the pain is having a significant impact on the patient's quality of life; o there is no psychological contraindication, drug seeking behaviour or history of drug misuse.

m-Eslon SR Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

m-eslon sr

multichem nz limited - morphine sulfate pentahydrate 200mg;   - modified release capsule - 200 mg - active: morphine sulfate pentahydrate 200mg   excipient: dibutyl sebacate ethylcellulose gelatin macrogol 4000 purified talc sugar spheres - for the prolonged relief of chronic, moderate to severe pain in adults. use in non-malignant pain: the use of m-eslon sr tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: o all other conservative methods of analgesia have been tried and have failed; o the pain is having a significant impact on the patient's quality of life; o there is no psychological contraindication, drug seeking behaviour or history of drug misuse.

m-Eslon SR Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

m-eslon sr

multichem nz limited - morphine sulfate pentahydrate 30mg;   - modified release capsule - 30 mg - active: morphine sulfate pentahydrate 30mg   excipient: dibutyl sebacate erythrosine ethylcellulose gelatin   macrogol 4000 purified talc sugar spheres titanium dioxide - for the prolonged relief of chronic, moderate to severe pain in adults. use in non-malignant pain: the use of m-eslon sr tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: o all other conservative methods of analgesia have been tried and have failed; o the pain is having a significant impact on the patient's quality of life; o there is no psychological contraindication, drug seeking behaviour or history of drug misuse.